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Whole-body irradiation of a  variety of inbred strains of mice has been shown to 
induce thymic lymphomas (1-3). Although considerable research has been directed at 
the etiology of radiation-induced leukemia in strains of mice such as  C57BL, the 
factors involved are still problematical. Initially it was proposed that primary tumors 
in irradiated mice were induced by the activation of a latent endogenous C-type virus, 
based on the observation that leukemogenic viruses could be obtained by continued 
passage of  cell-free extracts (4-6). However, detailed serological and virological studies 
have demonstrated that there is little correlation between endogenous ecotropic virus 
expression  and induction of leukemia by irradiation in C57BL/6 mice (7-9).  More- 
over, irradiation induces leukemia in mice such as the NIH Swiss (10) and C57L (11) 
which genetically lack an endogenous ecotropie C-type virus. Serological  and struc- 
tural analyses of the virus isolated from radiation-induced leukemia indicate that this 
virus may be a recombinant virus which may have developed after the primary event 
of radiation-induced leukemia  (12). Thus,  it  appears  that  the primary etiological 
factor in radiation-induced leukemia does not involve complete endogenous ecotropic 
C-type virus expression. Therefore, this disease is quite distinct from the spontaneous 
leukemias in AKR mice, which are more clearly associated  with active replication of 
endogenous ecotropic C-type viruses (13, 14). 
In  spite  of the lack of a  consistent etiological  factor associated  with radiation- 
induced  leukemia,  a  number  of biological  phenomena  have  been  described  for 
radiation-induced leukemias  which  bear  directly on  the  possible  mechanisms of 
induction. First, the regimen of irradiation has been shown to be extremely important 
(3), in that a single irradiation of 350 rads is only weakly leukemogenic, whereas four 
weekly doses of 175  rads is highly leukemogenic.  This observation argues against a 
simple  mechanism of somatic mutation and  supports  a  more  complex  inductive 
mechanism (6). A second observation is that the primary leukemogenic effects are in 
the bone marrow. This is illustrated by the ability to block the leukemogenic effect of 
whole-body irradiation by shielding the legs (15) and by the observation that early 
after irradiation, preleukemic cells can be transferred to appropriate recipients by 
bone marrow cells but not by thymocytes (16). This effect is also evident by the ability 
to induce leukemia in thymeetomized mice which have received  a  normal thymus 
* Research sponsored by  the  National  Cancer  Institute under contract-N01-CO-75380  with  Litton 
Bionetics, Inc, 
13 38  J. ExP. MED. © The Rockefeller University Press . 0022-1007/78/1101-133851.00 
Volume 148  November 1978  1338-1350 N. H. PAZMII~O, R.  MeEWAN, AND J.  N. IHLE  1339 
transplant after irradiation (17,  18). A third observation is that, although the primary 
effects of irradiation  are  in  the bone marrow,  the  thymus  is required  for ultimate 
expression of the neoplastic state (6, 17). Lastly, a striking effect in radiation leukemia 
is  the  ability  of normal  bone  marrow  reconstitution  after irradiation  to  abrogate 
leukemia induction (19). This effect provides a strong argument against the concept 
of an  infectious process  and  suggests  a  primary  effect on  bone  marrow  stem  cell 
populations. Taken together, these observations suggest that radiation-induced leu- 
kemia is associated with specific alterations in the early stages of thymoeyte differen- 
tiation occurring in the bone marrow. 
In  an  effort  to  study  the  changes  induced  by  irradiation  in  early  thymocyte 
differentiation, we have studied the distribution and regulation of  the enzyme terminal 
deoxynucleotidyl transferase (TdT) a in mice. This enzyme has been purified and its 
in vitro activity characterized (20-22). TdT has been found only in thymocytes and 
bone marrow in a  variety of species. In the thymus, TdT is restricted to the major 
thymocyte subpopulation characterized by cortisone sensitivity and moderate density 
(23-25). In the bone marrow, TdT is associated with a minor subpopulation separable 
on bovine serum albumin  (BSA) discontinuous gradients (26). It has been suggested 
that  the expression of TdT in the bone marrow is associated with a  prothymocyte 
stem  cell,  based  on  the  observation  that  treatment  of bone  marrow  cells  with 
thymopoietin induces the expression of theta on TdT-containing cells (27). Similarly, 
the  expression  of TdT  in  this  bone  marrow  subpopulation  is  thymic-dependent, 
because only low levels of TdT are found in nude or thymectomized mice but can be 
induced  both  in  vivo and  in  vitro  with  thymosin  fraction V,  a  thymic hormone 
preparation  (28,  29).  These  results  have  therefore strongly  suggested  a  proposed 
pathway of differentiation involving the  thymic hormone-dependent, induction  of 
TdT, followed by the induction of 0 and presumably subsequent  migration to the 
thymus. In the present studies we have utilized this information to assess the changes 
that occur in these populations which are specific to leukemogenie doses of irradiation. 
The results demonstrate that very striking changes are induced which correlate with 
the ultimate induction of leukemia. 
Materials and Methods 
Mice.  C57BL/6 and NIH Swiss nu/nu specific pathogen-free mice used in these experiments 
were obtained from the Frederick Cancer Research Center's Animal Production Area (Frederick, 
Md.). Ages of different mice are given in Results. 
Cell Fractionation.  Preparation of the cells and subsequent  fractionation on discontinuous 
BSA gradients have been described previously (26). 
Enzyme  Preparation.  Preparation  of crude cell-free  extracts  and  enzyme purification on 
phosphocellulose  pll columns (Whatman, Inc., Clifton,  N. J.) have been described  previously 
(25). 
TdT Assay.  The TdT assay, adapted from Kung et al. (23), has been previously described 
(25). 1 U of enzyme activity is defined as the amount catalyzing the incorporation of 1 pmol of 
deoxyguanosine 5'-trlphosphate (dGTP) into acid-insoluble material per hour. Specific activity 
was calculated from the total enzyme activity recovered from phosphoeellulose per l0  s nucleated 
viable cells. Under the conditions of the assay, the lowest activity detectable is "0.05 pmol of 
dGTP incorporated. 
1  Abbreviations used in this paper: BSA, bovine serum albumin; dGTP, deoxyguanosine  5'-triphosphate; 
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FIG.  1.  The effect of irradiation on the number of thymus cells. C57BL/6 mice, 4-wk-old, were 
irradiated at weekly intervals with  175 rads either once (C)), three times ([[1), or four times (A). 
Thymocyte numbers were determined as described in Materials and Methods and are expressed as 
the percentage of the number of thymocytes found in unirradiated, control mice. Percentages are 
the average from three to five individual mice at each point. 
Thymectomy.  3-wk-old  C57BL/6 mice were thymectomized according to the procedure of 
Sjodin et al.  (30). 
In  Vitro Induction.  For  induction experiments, cells  were  washed  three  times  after  BSA 
gradient fractionation in Ham's F-12 medium containing 100 U/ml penicillin and 100/~g/ml 
streptomycin. After being washed, cell concentrations were adjusted to 1 X  l0  s cells/ml in the 
same medium containing antibiotics, 20% fetal bovine serum (Flow Laboratories, Inc., Rock- 
ville, Md.), and different concentrations of thymosin or spleen fraction V, and f13, a thymosin 
component. After incubation for 12 h, cells were washed twice with Ham's F-12, and extracted 
as described previously for TdT activity (28). 
Radiation.  Mice were irradiated with the doses and at the ages indicated in Results by the 
method previously described (8). The source was a Phillips MG-301 X-ray therapy unit (Phillips 
Electronic Instruments, Mount Vernon, N. Y.) with a 0.2-ram  3 filter operated at  10 mA and 
300 kV with a dose rate of 175 rads/min. 
Bone Marrow Reconstitution.  The day after the last irradiation, the mice were given 1 ×  l07 
bone marrow cells from 4-wk-old C57BL/6 mice by intravenous injection. 
Results 
The effects of 1, 3, or 4 whole-body weekly irradiations with 175 rads on the thymus 
cell number are shown in Fig.  1. Each regimen of irradiation results in an initial loss 
of thymocytes of between 60 and 80% at  1 wk post-irradiation. With  1  ×  175  rads 
there  is a  subsequent repopulation such that  at  3-4 wk postirradiation 90%  of the 
initial cell number is  present.  With either 3  or  4  ×  175  rads,  repopulation of the 
thymus after the last irradiation occurs somewhat slower and recovery at 4 wk is only 
-60-80% of the cell number found in unirradiated controls. As previously reported 
(8),  the  leukemia incidences in C57BL/6  mice given  1,  3,  or  4  weekly irradiations 
with 175 rads are ~0, 4, and 70%, respectively. The peak incidence of leukemia occurs 
at 4-5 mo after the last irradiation in mice treated with 4  X  175 rads. 
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FIG.  2.  The effect of irradiation on TdT activity in thymus and bone marrow. C57BL/6 mice at 
4 wk of age were irradiated (either once [O], twice [Q], three times [A], or four times [A]) at weekly 
intervals  with  175  rads.  The  specific  activity  of TdT  peaks  I  and  II  was  determined  after 
phosphocellulose pll chromatography as described in Materials and Methods. TdT activity associ- 
ated with thymocytes is shown in the top panel and ~I'dT associated with fraction A ceils of BSA 
gradient fractionated bone marrow cells is shown in the bottom panel. Each point represents the 
activity found in three to five pooled thymuses or the pooled bone marrow cells from 20-30 mice. 
The  data  are expressed as the percentage of the specific activity  found  in  thymocytes or bone 
marrow cells of unirradiated control mice. 
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marrow cells of mice irradiated with 1, 2, 3, or 4 weekly doses of 175 rads is shown in 
Fig. 2. To compensate for the changes in total cell numbers, the data are presented as 
the  specific activity  (enzyme activity per  108 cells)  expressed as  the percentage of 
nonirradiated controls. Because TdT activity is associated with two enzymatic peaks 
of activity separable on phosphocellulose (23,  25), peak I and II activities are shown 
separately in  Fig.  2.  The TdT activity in  the bone marrow has  been shown  to be 
associated with a  minor subpopulation of cells separable on BSA gradients  (26) and 
the results presented here represent the specific activity in bone marrow fraction A 
cells. In the thymus and bone marrow, TdT peak I and II activities were dramatically 
reduced  1 wk  after a  single  irradiation  with  175  rads.  Subsequently,  the  specific 
activity of peak I  and  II activities in the thymus and bone marrow increased such 
that by 4 wk postirradiation the specific activity of TdT was comparable to untreated 
controls. With either two or three weekly doses of 175 rads,  the specific activity of 
TdT was similarly reduced and recovered with time, although recovery took consid- 
erably longer and the specific activity of TdT in the bone marrow returned to only 
~50%  of the control values. With  four weekly irradiations of 175 rads,  the specific 
activity of TdT was initially reduced to undetectable levels in both the thymus and 
bone marrow  fraction A  cells.  In  the bone marrow, TdT activity remained  below 
detectable levels for at  least  18 wk  after the  last  irradiation.  In  the  thymus,  TdT 
activity remained at levels of <20% of that found in control unirradiated mice. These 
results demonstrate that one consequence of the leukemogenic dose of irradiation (4 
×  175  rads)  is  the  striking  reduction  or elimination  of TdT  activity in  both  the 
thymus and bone marrow.  Because the results are expressed as the specific activity 
and, as shown in Fig.  1, cellular reconstitution of the thymus occurs at 4 wk after the 
last irradiation, the reduction of TdT activity indicates the specific loss of a subpop- 1342  RADIATION-INDUCED CHANGES  IN TdT  EXPRESSION 
TABLE I 
Correlation of TdT Expression and Overt Leukemia in Thymocytes  from 
Individual Mice After Irradiation* 
Wk Post-ir-  Mouse No.  Tumor status  radiation 
sp act TdT 
I  II 
1  6  Normal  37  98 
2  8  Thymoma:]:  347  753 
3  10  Normal  17  155 
4  16  Thymoma  3,612  1,872 
5  16  Normal  21  137 
6  20  Normal  19  81 
7  22  Thymoma  2,982  926 
Unirradiated con-  16  Normal  424  1,937 
trol 
* c57BL/6 mice were irradiated with four weekly doses of 175 rads beginning 
at 1 mo of age. Individual mice were examined at the indicated times for the 
levels of TdT in thymocytes as described in Materials and Methods. Specific 
activity of TdT is the picomoles of dGTP incorporated  per hour per 108 
nucleated  viable thymocytes.  Normal  mice were those showing no  gross 
evidence of thymus  enlargement  indicative  of the onset  of leukemia  or 
enlargement of peripheral lymphoid tissues. 
:~ This particular thymnma was at a very early stage of development as judged 
by only a  two- to threefold  thymus  enlargement  and no  involvement of 
peripheral sites. The other cases were overt thymomas with grossly enlarged 
thymuses and peripheral involvement. 
ulation of cells which expresses TdT. It should also be noted that loss of TdT  in the 
thymus or bone marrow was not associated with the appearance of TdT-positive cells 
in  the  spleen  or  lymph  nodes  and  there  was  no  expression  of TdT  in  the  other 
fractions of bone marrow cells (data not shown). 
The relationship of TdT  expression to the subsequent  development of leukemia is 
shown in Table I. As previously demonstrated, radiation-induced thymic lymphomas 
of C57BL mice are TdT-positive (25). The thymic-localized cells express peaks I  and 
II  at  levels  comparable  to  age-matched  nonirradiated  controls,  whereas  leukemic 
thymocytes infiltrating peripheral lymphoid tissues generally have only peak I activity. 
As shown  in Table I, high levels of TdT  activity in the thymus were only detectable 
in overtly leukemic mice. Irrespective of the time after irradiation, mice that were not 
overtly leukemic had the characteristic low levels of TdT.  Interestingly, mice which 
survived past the peak of tumor incidence (longer than 4 too) similarly had low levels 
of TdT  activity. These  results suggest  that  the reappearance of high  levels of TdT 
activity is correlated with the onset of the overtly leukemic phase. 
To  examine further  the correlation of the loss of TdT  with  the ability to induce 
leukemia, we examined the effect of 350  rads and  bone  marrow  reconstitution of 4 
×  175  rads-treated  mice  on  TdT  expression.  As  previously  described,  a  single 
irradiation  of  350  rads  induces  incidences  of  leukemia  of  <5%  compared  with 
incidences  of >70%  with  the  fractionated  regimen  (8).  As  shown  in  Fig.  3,  both 
regimens of irradiation initially eliminated detectable TdT activity; however, in mice 
treated with 350 rads, TdT  activity was rapidly recovered, whereas no such recovery 
was seen in 4  ×  175 rads-treated mice. The ability of bone marrow reconstitution to N.  H.  PAZMINO,  g.  McEWAN,  AND .J.N.  IHLE 
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FIG.  3.  Differential effects of 350 fads and 4  X  175 rads on thymus TdT activity. C57BL/6 mice 
at 4 wk of age were irradiated either once with 3.50 rads or were irradiated with four weekly doses 
of 175  rads. TdT activity in  thymocytes was determined at  2  and 3  wk after the completion of 
irradiation  as  described  in  Materials  and  Methods.  The  specific  activity  was  determined  from 
pooled thymocytes from three to five mice in each case. 
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FIG.  4.  The effect of bone marrow reconstitution on thymocyte TdT activity in mice given 4  × 
17.5 fads.  C57BL/6  mice  at  4  wk  of age  were  irradiated  with  four  weekly  doses of  175  rads. 
Immediately after  the  last  irradiation,  the experimental group was  reconstituted  with  1  X  10  7 
normal bone  marrow  cells from 4-wk-old C57BL/6  mice. The levels of TdT were subsequently 
examined at  2, 6, and  10 wk as described in Materials and Methods. TdT activity in the thymus 
was determined from pooled thymuses of three to five mice. TdT activity in the bone marrow was 
determined using BSA gradient  fractionated  bone marrow cells from 20-30  mice.  Bone marrow 
TdT activity is that associated with BSA gradient fraction A cells. 
abrogate induction  of leukemia by 4  z  175  rads has been described  previously (8, 
19).  We therefore  examined  TdT  levels in  control  and  bone  marrow-reconstituted 
mice. As shown in Fig. 4, bone marrow reconstitution of 4  X  175 rads-treated mice 1344  RADIATION-INDUCED CHANGES IN TdT EXPRESSION 
TABLE II 
Differential Effects of 4  ×  175 rads on  TdT Activity in Mice of Various 
Ages 
Age at start of irradia- 
tion 
TdT Activity (% of control)* 
I  II 
mo 
1  8.7  5.0 
2  20.5  18.1 
3  96.7  86.6 
" C57BL/6 mice at 1, 2, or 3 mo of age were given four weekly doses of 4 x 
175 rads. The thymocyte TdT activity was determined  1 mo after the last 
irradiation  as  described in  the  Materials  and  Methods. The  results are 
presented as the percentage of activity found in unirradiated normal control 
mice. 
resulted  in  a  rapid  reappearance  of TdT  in  the  thymus  1 wk  after  reconstitution. 
Interestingly, the specific activity of TdT in the thymus was approximately twice the 
control  levels  at  1  wk  and  decreased  to  normal  levels  by  6  wk.  In  contrast,  the 
reappearance of TdT activity in the bone marrow was slower, although by 6 wk after 
reconstitution,  normal  levels  were  present.  The  above  results  therefore  illustrate  a 
striking  correlation  between  the  loss or recovery of TdT  activity  and  the  ultimate 
induction or lack of induction of thymic lymphomas. 
To  test  further  the  correlation  of the  loss of TdT  activity with  the  induction  of 
leukemia,  we  examined  the  effect  of 4  ×  175  rads  on  mice  of various  ages.  As 
previously demonstrated  (8,  31),  the  ability of 4  ×  175  rads  to induce  leukemia  is 
highly age-dependent such that irradiation of mice at  1, 2, or 3 mo of age at the start 
of the regimen resulted in incidences of 75, 53, and 25%, respectively. As illustrated  in 
Table II, there is also a striking age-dependent effect on the recovery of TdT activity 
when  examined  1 mo after  the last  irradiation.  As above, mice at  1 mo of age had 
<10%  of the  normal  levels  of TdT.  Mice  irradiated  at  2  mo of age  similarly  had 
reduced levels of TdT, although these levels were ~30% of the normal. Mice irradiated 
at 3 mo of age had essentially normal levels of TdT by 1 mo postirradiation.  Thus, as 
above,  the  ability  to  induce  leukemia  is  strongly  correlated  with  changes  in  TdT 
levels. 
The loss of TdT-positive cells after leukemogenic doses of irradiation could be due 
to  the  absence  of  the  requisite  factors  for  differentiation.  Because  it  has  been 
demonstrated  that  thymosin  fraction V  can  induce  the  expression  of TdT  in  bone 
marrow cells from athymic mice both in vivo and in vitro (28, 29), we examined cells 
from various tissues of 4  ×  175 rads-treated mice for their responsiveness to thymosin 
fraction V  in vitro. As shown in Table III, no inducible cell populations were observed 
in 4  ×  175 rads-irradiated  mice. These results suggest that the absence of TdT is not 
simply due to the absence of the requisite factors for induction but rather appears to 
be due to a  more complex effect on the responsive stem cell population. 
To examine the effect of 4  ×  175 rads on presumptive TdT-positive stem cells, we 
examined  the effect  of irradiation  on thymectomized mice.  As previously described 
(28),  thymectomy  results  in  a  loss  of TdT  activity  in  the  bone  marrow  and  the 
accumulation  of a  presumptive  stem  cell,  which  under  the  influence  of thymosin N.  H.  PAZMIlqO,  R.  McEWAN, AND J.  N.  IHLE  1345 
TABLE  III 
Lack of Induction of TdT Activity in Thymus, Spleen, and Lymph Nodes  from 4  X  175 rads-Irradiated 
Mice 
Wk Post- 
irradia- 
tion 
Peak 
Thymus  Spleen  Lymph nodes 
Control  Thymosin  Control  Thymosin  Control  Thymosin 
1  I  ND  ND  3.8  4.9  ND  ND 
II  ND  ND  5.2  3.0  ND  ND 
2  I  ND  ND  <0.1  1.5  ND  ND 
II  ND  ND  <0.1  4.0  ND  ND 
4  I  11  17  1  <0.1  ND  ND 
II  29  41  <0.1  <0.1  ND  ND 
8  I  12  19  7.8  7.3  ND  ND 
II  31  20  6.4  4.1  ND  ND 
16  I  21  27  4.3  5.4  8.7  3.8 
II  35  48  6.8  7.9  <0.1  <0.1 
C57BL/6  mice were irradiated beginning at  I  mo of age  with four weekly  doses of 175  rads.  At  the 
indicated times,  various  lymphoid tissues were obtained and cell suspensions  prepared as indicated in 
Materials and Methods. In  the case  of spleen and lymph node cells, the cell  suspensions  were further 
fractionated on BSA gradients and fraction B cells were used. The cells were subsequently incubated in 
media containing 25 ng/ml thymosin fraction V or saline for controls.  After 12 h, the cells were extracted 
and assayed for TdT activity as described in Materials and Methods. 
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Fxo. 5.  In  vitro induction of TdT  in bone marrow cells from thymectomized irradiated mice. 
C57BL/6 mice at 4 wk of age were thymectomized and irradiated with four weekly doses of 175 
rads beginning at 5 wk of age. For induction experiments, bone marrow cells were collected from 
20-30  mice at 4 wk after the last  irradiation and fractionated on BSA gradients. Fraction B cells 
were used as previously  described (28) for induction of TdT.  Bone marrow cells were incubated 
with either thymosin fraction V or saline at 5  x  10  s cells/ml for 12 h at 37°C in Ham's F-12 as 
described in Materials and Methods. TdT activity was determined after phosphocellulose  chroma- 
tography as described in Materials and Methods. 
fraction  V  can  be  induced  to  express  TdT.  In  the  experiment  shown  in  Fig.  5, 
C57BL/6  mice were thymectomized  and  then  given either no  irradiation,  1  X  350 
rads, or 4  X  175 rads. As illustrated by the results, TdT  activity was induced in bone 
marrow  fraction B  cells from nonirradiated mice or mice given the nonleukemogenic 
dose of irradiation,  but  was not  inducible in  cells from mice treated with 4  X  175 
rads. These results indicate that  leukemogenic doses of irradiation specifically elimi- 1346  RADIATION-INDUCED  CHANGES IN TdT EXPRESSION 
nate or alter the bone marrow stem cell population inducible for TdT. Furthermore, 
these  results  indicate  that  the  loss  of the  TdT  stem  cell  is  thymus-independent, 
suggesting that the primary effect of irradiation is only in the bone marrow. 
Discussion 
The results  demonstrate that  leukemogenic doses of irradiation specifically alter 
the normal differentiation of TdT-positive cells in bone marrow and thymus. This is 
manifested by the lack of the repopulation of bone marrow and thymus with TdT- 
positive cells after recovery of an initial radiation-induced loss of cells. The correlation 
of this response to induction of thymic lymphomas was demonstrated in several ways. 
It  has  been  previously demonstrated  that  the  ability of whole-body irradiation  to 
induce leukemia is highly dependent upon a fractionated regimen and that a striking 
increase in the incidence of leukemia is only seen after four weekly doses of 175 rads 
(3, 8). As shown here, the ability of irradiation to eliminate TdT-positive cells during 
thymic repopulation was similarly dependent in that  in those mice given  1, 2, or 3 
X  175 rads, TdT activity was recovered, whereas little recovery of TdT activity was 
seen in mice given 4  X  175 rads. Also, when mice were given the nonleukemogenic 
dose of a single treatment with 350 rads, TdT activity returned to normal levels with 
time after irradiation. When the leukemogenic effect of 4  X  175 fads was abrogated 
by reconstitution with normal bone marrow immediately after the last irradiation, 
normal levels of TdT activity were obtained in both bone marrow and thymus within 
6  wk  after reconstitution. The age-dependent  loss  of susceptibility to induction  of 
leukemia by 4  ×  175 rads was similarly correlated with the ability to recover TdT 
activity in  the  thymus. Thus,  the  phenotypic loss  of TdT-positive cells is  strongly 
correlated with the subsequent development of thymic lymphomas. 
The molecular basis for the changes in TdT levels induced by leukemogenic doses 
of irradiation is not known. The most obvious explanation for the lack of a differen- 
tiation-specific enzyme such as TdT is the loss of the factors required for induction of 
differentiation. Because we have previously demonstrated that thymosin fraction V 
can induce TdT in a  presumptive pre-T-cell from the prothymocyte bone marrow 
population  (28,  29),  we  examined  4  X  175  fads-treated  mice  for  inducible  cell 
populations.  The results clearly demonstrate the lack of any such cells even in the 
bone marrow, suggesting that the lack of  TdT expression is more complex than simply 
the absence of the appropriate factors required for induction. The complexity of the 
effect was even more evident in the results using irradiated, thymectomized mice. In 
particular, 4  X  175 rads irradiation of thymectomized mice appears to have elimi- 
nated the presumptive stem cell which normally is inducible by thymosin fraction V 
to express TdT. Again, this effect was specific for leukemogenic doses of irradiation in 
that a comparable effect was not seen in thymectomized mice given 350 rads. These 
results also suggest that the initial effects observed on TdT expression are probably 
thymus-independent, the primary effect being in presumptive stem cell populations 
in the bone marrow. This result is consistent with a number of biological experiments 
which have demonstrated that the primary leukemogenic effects of irradiation are in 
the bone marrow and are thymus-independent (6, 16, 32). 
In spite of the lack of recovery of TdT activity in the thymus after leukemogenic 
doses of irradiation, the thymus does become repopulated. Several questions therefore 
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results have demonstrated that the onset of leukemia is associated with and actually 
predictable by the reappearance of TdT. This would argue against the leukemic cell 
population emerging from the cell population found in the thymus after irradiation, 
although phenotypic changes in this population, perhaps  associated with transfor- 
mation, must be considered. More importantly, however, it has been demonstrated 
that during the preleukemic phase, transfer of bone marrow cells but not thymocytes 
can produce leukemia (16). This observation suggests that in fact the leukemogenic 
potential is not associated with the thymus-repopulating cells, but  rather with an 
altered  bone  marrow  stem  cell  population.  The  properties  and  the  origin  of the 
thymus-repopulating cells are largely unknown. Two possibilities include repopulation 
by cells of a lineage distinct from the lineage that expresses TdT or repopulation by 
cells of the appropriate lineage, but which because of somatic alterations or alterations 
in  differentiation do not express TdT.  Although we cannot presently differentiate 
between these possibilities, we have observed an increase in the specific activity of the 
enzyme 20-a-hydroxysteroid dehydrogenase in the repopulating thymocytes (unpub- 
lished data).  Because this enzyme has been  shown to be a  specific marker for the 
minor thymocyte population (33), it appears that the repopulated thymus may have 
an  altered  distribution  of the  major  and  minor  populations.  Unfortunately,  the 
relationship  of the  major  and  minor  populations  in  differentiation has  not  been 
clarified to determine whether unique cell lineages are involved. 
The results reported here as well as previous results suggest a possible mechanism 
for the induction of leukemia by irradiation. In particular it appears that an initial 
effect of leukemogenic doses of irradiation is the reduction or elimination of a bone 
marrow stem cell population which can be induced to express TdT. The second phase 
of leukemia induction then involves the repopulation of the thymus with ceils of a 
lineage which we feel is distinct from the TdT-positive cell lineage. This population 
may be of the cortisone-resistant, TdT-negative, minor thymocyte population. As a 
consequence  of this  aberrant  repopulation,  we  propose  a  third  phase  in  which 
differentiation of TdT-positive cells may be actively suppressed. This is suggested by 
the time-dependent loss of the ability of normal bone marrow reconstitution to either 
abrogate leukemia (6, 19) or allow normal recovery of TdT-positive cells (unpublished 
data). This active suppression of differentiation of bone marrow stem cells could be 
mediated by thymic factors which antagonize the ability of the requisite factors to 
induce  TdT-positive  cells.  Interestingly, we  have  recently  demonstrated  that  the 
induction of TdT by thymosin fraction V  is concentration-dependent and that at 
high concentrations there is a marked inhibition of induction; whereas the concentra- 
tion curve for the appropriate peptide hormone, ~a, purified from thymosin fraction 
V, shows no inhibition of induction at high concentrations (29).  These results have 
been interpreted to suggest that thymosin fraction V  contains a  factor(s) which can 
suppress  differentiation of TdT-positive  cells,  and  thus  a  balance  in  appropriate 
factors may be essential to promote normal differentiation. The last phase in leukemia 
induction we envision involves an aberrant stem cell of the TdT-positive cell lineage 
which, because of the suppressive environment established by irradiation, emerges as 
a population lacking the ability to respond to normal controls in differentiation and 
thus resulting in uncontrolled proliferation. Such an aberrant population could arise 
by somatic mutation, phenotypic instability, changes induced by endogenous viruses, 
etc. Irrespective of the mechanism, the emergence of such cells is strongly implied by 1348  RADIATION-INDUCED CHANGES IN TdT EXPRESSION 
the reappearance of TdT-positive cells as a prelude to overt leukemia and the lack of 
reappearance of such cells in  "survivors." If correct, this hypothesis provides several 
opportunities  for the  regulation  of the  onset  of leukemia.  In particular  it  appears 
possible that elimination of specific factors, such as 83,  which promote early steps of 
differentiation  of TdT-positive cells may block the subsequent  emergence of trans- 
formed cells. This is suggested by the observation that overtly transformed T  cells do 
not arise in irradiated,  thymectomized mice, although transfer of bone marrow cells 
to thymus-bearing recipients can transfer leukemia (16).  Secondly, it may be possible 
to alter the cell populations found in the thymus postirradiation by thymic factors to 
allow  a  "normal"  distribution  of cell  types.  Athough  parts  of this  hypothesis  are 
untested,  it appears to be consistent with the known properties of radiation-induced 
leukemia.  More  importantly,  however,  the  recent  development of several  new  ap- 
proaches to the study of T-cell differentiation and leukemia has provided the means 
to critically assess the hypothesis presented here. 
Summary 
The expression of terminal deoxynucleotidyl transferase (TdT) in the thymus and 
bone marrow of irradiated  mice has been examined.  Mice  given the leukemogenic 
regimen of irradiation of four weekly doses of 175 rads starting at  1 mo of age show 
a long-term elimination of TdT activity in the bone marrow and a reduction of TdT 
activity in thymocytes. In such mice, the reappearance of normal levels of TdT in the 
thymus appears to only be associated with the onset of overt leukemia. This effect on 
TdT expression was shown to be uniquely associated with the leukemogenic regimen 
of irradiation in that nonleukemogenic irradiation or variations such as bone marrow 
reconstitution  or  age  which  reduce  leukemias  did  not  show  the  same  phenotypic 
effects on TdT expression. The basis for the loss of TdT-positive cells was shown not 
to be due to the lack of the requisite factors involved in differentiation, but rather to 
the ability of leukemogenic doses of irradiation  to reduce or eliminate an inducible 
bone  marrow  stem  cell.  These  results  are  discussed  with  respect  to  the  possible 
mechanisms involved in radiation-induced leukemias in mice. 
Received  for publication 6July 1978. 
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